Literature DB >> 30806485

Milestone prediction for time-to-event endpoint monitoring in clinical trials.

Fang-Shu Ou1, Martin Heller2, Qian Shi1.   

Abstract

Predicting the times of milestone events, ie, interim and final analyses in clinical trials, helps resource planning. This manuscript presents and compares several easily implemented methods for predicting when a milestone event is achieved. We show that it is beneficial to combine the predictions from different models to craft a better predictor through prediction synthesis. Furthermore, a Bayesian approach provides a better measure of the uncertainty involved in prediction of milestone events. We compare the methods through two simulations where the model has been correctly specified and where the models are a mixture of three incorrectly specified model classes. We then apply the methods on two real clinical trial data, North Central Cancer Treatment Group (NCCTG) N0147 and N9841. In summary, the Bayesian prediction synthesis methods automatically perform well even when the data collection is far from homogeneous. An R shiny app is under development to carry out the prediction in a user-friendly fashion.
© 2019 John Wiley & Sons, Ltd.

Entities:  

Keywords:  clinical trial; density forecast combination; event modeling; model stacking; prediction synthesis; trial monitoring

Mesh:

Year:  2019        PMID: 30806485      PMCID: PMC6777948          DOI: 10.1002/pst.1934

Source DB:  PubMed          Journal:  Pharm Stat        ISSN: 1539-1604            Impact factor:   1.894


  12 in total

1.  Predicting analysis times in randomized clinical trials.

Authors:  E Bagiella; D F Heitjan
Journal:  Stat Med       Date:  2001-07-30       Impact factor: 2.373

2.  Discussion on the paper "Real-Time Prediction of Clinical Trial Enrollment and Event Counts: A Review", by DF Heitjan, Z Ge, and GS Ying.

Authors:  Vladimir V Anisimov
Journal:  Contemp Clin Trials       Date:  2015-11-10       Impact factor: 2.226

3.  Nonparametric prediction of event times in randomized clinical trials.

Authors:  Gui-shuang Ying; Daniel F Heitjan; Tai-Tsang Chen
Journal:  Clin Trials       Date:  2004       Impact factor: 2.486

4.  Predicting accrual in clinical trials with Bayesian posterior predictive distributions.

Authors:  Byron J Gajewski; Stephen D Simon; Susan E Carlson
Journal:  Stat Med       Date:  2008-06-15       Impact factor: 2.373

Review 5.  Real-time prediction of clinical trial enrollment and event counts: A review.

Authors:  Daniel F Heitjan; Zhiyun Ge; Gui-Shuang Ying
Journal:  Contemp Clin Trials       Date:  2015-07-16       Impact factor: 2.226

6.  Adaptive parametric prediction of event times in clinical trials.

Authors:  Yu Lan; Daniel F Heitjan
Journal:  Clin Trials       Date:  2018-01-29       Impact factor: 2.486

7.  Planning the duration of a comparative clinical trial with loss to follow-up and a period of continued observation.

Authors:  L V Rubinstein; M H Gail; T J Santner
Journal:  J Chronic Dis       Date:  1981

8.  Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841.

Authors:  George P Kim; Daniel J Sargent; Michelle R Mahoney; Kendrith M Rowland; Philip A Philip; Edith Mitchell; Abraham P Mathews; Tom R Fitch; Richard M Goldberg; Steven R Alberts; Henry C Pitot
Journal:  J Clin Oncol       Date:  2009-04-20       Impact factor: 44.544

9.  Modelling, prediction and adaptive adjustment of recruitment in multicentre trials.

Authors:  Vladimir V Anisimov; Valerii V Fedorov
Journal:  Stat Med       Date:  2007-11-30       Impact factor: 2.373

10.  Predicting analysis times in randomized clinical trials with cancer immunotherapy.

Authors:  Tai-Tsang Chen
Journal:  BMC Med Res Methodol       Date:  2016-02-01       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.